Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门评论

chuminhua2020-12-15 11:33

12/14,据彭博社援引匿名消息来源的报道称,Eidos Therapeutics于11月收到葛兰素史克(GlaxoSmithKline)的收购要约。Eidos已经同意BridgeBio Pharma的收购要约,该公司在最近的一份文件中披露,“大型国际制药公司”在11月下旬以每股120美元的全现金,无约束力的出价竞标了Eidos。
据彭博社报...查看全文

Eidos治疗(EIDX)2020-03-31 04:30

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-009640 Size: 10 KB 网页链接查看全文

Eidos治疗(EIDX)2020-03-24 18:15

$Eidos治疗(EIDX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-20-083086 Act: 34 Size: 32 KB 网页链接查看全文

Eidos治疗(EIDX)2020-03-05 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-006944 Size: 10 KB 网页链接查看全文

Eidos治疗(EIDX)2020-02-27 05:40

$Eidos治疗(EIDX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-006810 Act: 34 Size: 439 KB 网页链接查看全文

Eidos治疗(EIDX)2020-03-05 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-006941 Size: 5 KB 网页链接查看全文

Eidos治疗(EIDX)2020-02-27 05:50

$Eidos治疗(EIDX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-006823 Act: 34 Size: 12 MB 网页链接查看全文

Eidos治疗(EIDX)2020-02-19 19:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-005000 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2020-02-06 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-003247 Size: 15 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新评论

Eidos治疗(EIDX)2019-05-30 22:00

$Eidos治疗(EIDX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-05-30 AccNo: 0001193125-19-159860 Size: 35 KB 网页链接查看全文

Eidos治疗(EIDX)2019-05-08 09:35

$Eidos治疗(EIDX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-07 AccNo: 0001564590-19-016564 Size: 6 MB 网页链接查看全文

Eidos治疗(EIDX)2019-05-08 09:35

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-05-07 AccNo: 0001564590-19-016554 Size: 323 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Eidos治疗(EIDX)2019-04-30 09:40

$Eidos治疗(EIDX)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-29 AccNo: 0001193125-19-125291 Size: 538 KB 网页链接查看全文

Eidos治疗(EIDX)2019-04-15 21:45

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-04-15 AccNo: 0001564590-19-011571 Size: 435 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Eidos治疗(EIDX)2019-04-15 21:45

$Eidos治疗(EIDX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-15 AccNo: 0001564590-19-011575 Size: 20 MB 网页链接查看全文

美股律师郝俊波2019-04-02 10:48

$Eidos治疗(EIDX)$ Eidos Therapeutics Inc(NASDAQ: EIDX)因突发不利消息而令股价下跌,如果您投资该证券受损请点击我们的雪球网EIDX集体诉讼专题页:网页链接查看全文

Eidos治疗(EIDX)2019-04-02 09:35

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-04-01 AccNo: 0001193125-19-094700 Size: 22 KBItem 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review 网页链接查看全文

Eidos治疗(EIDX)2019-04-02 09:35

$Eidos治疗(EIDX)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2019-04-01 AccNo: 0001193125-19-094704 Size: 27 KB 网页链接查看全文

Eidos治疗(EIDX)2019-02-28 09:10

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-02-27 AccNo: 0001564590-19-004665 Size: 56 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15